The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP
Open accessAbstract
Among epigenetic "writers", "readers", and "erasers", the lysine methyltransferases G9a and GLP, which catalyze mono- and dimethylation of histone H3 lysine 9 (H3K9me2) and nonhistone proteins, have been implicated in a variety of human diseases. A "toolkit" of well-characterized chemical probes will allow biological and disease hypotheses concerning these proteins to be tested in cell-based and animal models with high confidence. We previously discovered potent and selective G9a/GLP inhibitors including the cellular chemical probe UNC0638, which displays an excellent separation of functional potency and cell toxicity. However, this inhibitor is not suitable for animal studies due to its poor pharmacokinetic (PK) properties. Here, we report the discovery of the first G9a and GLP in vivo chemical probe UNC0642, which not only maintains high in vitro and cellular potency, low cell toxicity, and excellent selectivity, but also displays improved in vivo PK properties, making it suitable for animal studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Bernstein, B. E., Meissner, A., & Lander, E. S. (2007) · Cell · doi:10.1016/j.cell.2007.01.033 · Cited by 2,086
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Graves, A. P., III, A. D. P., Diaz, E., et al. (2012) · Nature · doi:10.1038/nature11606 · Cited by 1,786
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Self-citationTachibana, M., Sugimoto, K., Nozaki, M., Ueda, J., Ohta, T., Ohki, M., Fukuda, M., Takeda, N., Niida, H., Kato, H., et al. (2002) · Genes & Development · doi:10.1101/gad.989402 · Cited by 1,253
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
Shi, Y., Desponts, C., Do, J. T., Hahm, H. S., Schöler, H. R., & Ding, S. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.004 · Cited by 902
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.017 · Cited by 859
Béguelin, W., Popovic, R., Teater, M., Jiang, Y., Bunting, K. L., Rosen, M., Shen, H., Yang, S. N., Wang, L., Ezponda, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.011 · Cited by 846
Tachibana, M., Ueda, J., Fukuda, M., Takeda, N., Ohta, T., Iwanari, H., Sakihama, T., Kodama, T., Hamakubo, T., & Shinkai, Y. (2005) · Genes & Development · doi:10.1101/gad.1284005 · Cited by 845
Knutson, S. K., Warholic, N. M., Wigle, T. J., Klaus, C. R., Allain, C. J., Raimondi, A., Porter Scott, M., Chesworth, R., Moyer, M. P., Copeland, R. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303800110 · Cited by 789
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Knutson, S. K., Wigle, T. J., Warholic, N. M., Sneeringer, C. J., Allain, C. J., Klaus, C. R., Sacks, J. D., Raimondi, A., Majer, C. R., Song, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1084 · Cited by 776
A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells
Shi, Y., Tae Do, J., Desponts, C., Hahm, H. S., Schöler, H. R., & Ding, S. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.05.011 · Cited by 671
Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity
Maze, I., Covington, H. E., Dietz, D. M., LaPlant, Q., Renthal, W., Russo, S. J., Mechanic, M., Mouzon, E., Neve, R. L., Haggarty, S. J., et al. (2010) · Science · doi:10.1126/science.1179438 · Cited by 665
Repression of p53 activity by Smyd2-mediated methylation
Huang, J., Perez-Burgos, L., Placek, B. J., Sengupta, R., Richter, M., Dorsey, J. A., Kubicek, S., Opravil, S., Jenuwein, T., & Berger, S. L. (2006) · Nature · doi:10.1038/nature05287 · Cited by 624
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Qi, W., Chan, H., Teng, L., Li, L., Chuai, S., Zhang, R., Zeng, J., Li, M., Fan, H., Lin, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210371110 · Cited by 547
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
Vedadi, M., Barsyte-Lovejoy, D., Liu, F., Rival-Gervier, S., Allali-Hassani, A., Labrie, V., Wigle, T. J., DiMaggio, P. A., Wasney, G. A., Siarheyeva, A., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.599 · Cited by 527
Self-citationProtein methyltransferases as a target class for drug discovery
Copeland, R. A., Solomon, M. E., & Richon, V. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2974 · Cited by 460
An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
Konze, K. D., Ma, A., Li, F., Barsyte-Lovejoy, D., Parton, T., MacNevin, C. J., Liu, F., Gao, C., Huang, X.-P., Kuznetsova, E., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400133j · Cited by 452
Self-citationG9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription
Tachibana, M., Matsumura, Y., Fukuda, M., Kimura, H., & Shinkai, Y. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.192 · Cited by 429
Target validation using chemical probes
Bunnage, M. E., Chekler, E. L. P., & Jones, L. H. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1197 · Cited by 421
Kleefstra, T., Brunner, H. G., Amiel, J., Oudakker, A. R., Nillesen, W. M., Magee, A., Geneviève, D., Cormier-Daire, V., van Esch, H., Fryns, J.-P., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/505693 · Cited by 393
G9a and Glp Methylate Lysine 373 in the Tumor Suppressor p53
Huang, J., Dorsey, J., Chuikov, S., Zhang, X., Jenuwein, T., Reinberg, D., & Berger, S. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.062588 · Cited by 383
Frye, S. V. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.296 · Cited by 375
Self-citationVerma, S. K., Tian, X., LaFrance, L. V., Duquenne, C., Suarez, D. P., Newlander, K. A., Romeril, S. P., Burgess, J. L., Grant, S. W., Brackley, J. A., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3003346 · Cited by 371
Protein lysine methyltransferase G9a acts on non-histone targets
Rathert, P., Dhayalan, A., Murakami, M., Zhang, X., Tamas, R., Jurkowska, R., Komatsu, Y., Shinkai, Y., Cheng, X., & Jeltsch, A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.88 · Cited by 347
Control of Cognition and Adaptive Behavior by the GLP/G9a Epigenetic Suppressor Complex
Schaefer, A., Sampath, S. C., Intrator, A., Min, A., Gertler, T. S., Surmeier, D. J., Tarakhovsky, A., & Greengard, P. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.019 · Cited by 317
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
Chang, Y., Zhang, X., Horton, J. R., Upadhyay, A. K., Spannhoff, A., Liu, J., Snyder, J. P., Bedford, M. T., & Cheng, X. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1560 · Cited by 308
Probing the Probes: Fitness Factors For Small Molecule Tools
Workman, P., & Collins, I. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.013 · Cited by 299
A Role for Repressive Histone Methylation in Cocaine-Induced Vulnerability to Stress
Covington, H. E., Maze, I., Sun, H., Bomze, H. M., DeMaio, K. D., Wu, E. Y., Dietz, D. M., Lobo, M. K., Ghose, S., Mouzon, E., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.007 · Cited by 289
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Yu, W., Chory, E. J., Wernimont, A. K., Tempel, W., Scopton, A., Federation, A., Marineau, J. J., Qi, J., Barsyte-Lovejoy, D., Yi, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms2304 · Cited by 281
Self-citationStructural Biology of Human H3K9 Methyltransferases
Wu, H., Min, J., Lunin, V. V., Antoshenko, T., Dombrovski, L., Zeng, H., Allali-Hassani, A., Campagna-Slater, V., Vedadi, M., Arrowsmith, C. H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008570 · Cited by 268
Self-citationKleefstra, T., van Zelst-Stams, W. A., Nillesen, W. M., Cormier-Daire, V, Houge, G., Foulds, N., van Dooren, M., Willemsen, M. H., Pfundt, R., Turner, A., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062950 · Cited by 252
Imai, K., Togami, H., & Okamoto, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103531 · Cited by 248
DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity
Dong, K. B., Maksakova, I. A., Mohn, F., Leung, D., Appanah, R., Lee, S., Yang, H. W., Lam, L. L., Mager, D. L., Schübeler, D., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.193 · Cited by 242
Liu, F., Chen, X., Allali-Hassani, A., Quinn, A. M., Wasney, G. A., Dong, A., Barsyte, D., Kozieradzki, I., Senisterra, G., Chau, I., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901543m · Cited by 239
Self-citationKondo, Y., Shen, L., Ahmed, S., Boumber, Y., Sekido, Y., Haddad, B. R., & Issa, J.-P. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002037 · Cited by 234
Liu, F., Chen, X., Allali-Hassani, A., Quinn, A. M., Wigle, T. J., Wasney, G. A., Dong, A., Senisterra, G., Chau, I., Siarheyeva, A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100478y · Cited by 205
Self-citationStructural Basis of Substrate Methylation and Inhibition of SMYD2
Ferguson, A. D., Larsen, N. A., Howard, T., Pollard, H., Green, I., Grande, C., Cheung, T., Garcia-Arenas, R., Cowen, S., Wu, J., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.011 · Cited by 203
Kondo, Y., Shen, L., Suzuki, S., Kurokawa, T., Masuko, K., Tanaka, Y., Kato, H., Mizuno, Y., Yokoe, M., Sugauchi, F., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00141.x · Cited by 203
Yuan, Y., Wang, Q., Paulk, J., Kubicek, S., Kemp, M. M., Adams, D. J., Shamji, A. F., Wagner, B. K., & Schreiber, S. L. (2012) · ACS Chemical Biology · doi:10.1021/cb300139y · Cited by 181
Moore, K. E., Carlson, S. M., Camp, N. D., Cheung, P., James, R. G., Chua, K. F., Wolf-Yadlin, A., & Gozani, O. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.03.005 · Cited by 165
Optimization of Cellular Activity of G9a Inhibitors 7-Aminoalkoxy-quinazolines
Liu, F., Baršytė-Lovejoy, D., Allali‐Hassani, A., He, Y., Herold, J. M., Chen, X., Yates, C. M., Frye, S. V., Brown, P. J., Huang, J. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200903z · Cited by 163
Self-citationYao, Y., Chen, P., Diao, J., Cheng, G., Deng, L., Anglin, J. L., Prasad, B. V. V., & Song, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206312b · Cited by 160
Watanabe, H., Soejima, K., Yasuda, H., Kawada, I., Nakachi, I., Yoda, S., Naoki, K., & Ishizaka, A. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-15 · Cited by 160
Sinefungin Derivatives as Inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2
Zheng, W., Ibáñez, G., Wu, H., Blum, G., Zeng, H., Dong, A., Li, F., Hajian, T., Allali‐Hassani, A., Amaya, M. F., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307060p · Cited by 157
Self-citationG9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitmentPreprint
Chen, X., Skutt-Kakaria, K., Davison, J., Ou, Y.-L., Choi, E., Malik, P., Loeb, K. R., Wood, B. L., Georges, G. E., Torok‐Storb, B., et al. (2012) · Genes & Development · doi:10.1101/gad.200329.112 · Cited by 147
Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases
Chang, Y., Ganesh, T., Horton, J. R., Spannhoff, A., Liu, J., Sun, A., Zhang, X., Bedford, M. T., Shinkai, Y., Snyder, J. P., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.048 · Cited by 126
Bioorthogonal Profiling of Protein Methylation Using Azido Derivative of S -Adenosyl- l -methionine
Islam, K., Bothwell, I. R., Chen, Y., Sengelaub, C. A., Wang, R. Y., Deng, H., & Luo, M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2118333 · Cited by 113
An Allosteric Inhibitor of Protein Arginine Methyltransferase 3
Siarheyeva, A., Senisterra, G. A., Allali‐Hassani, A., Dong, A., Dobrovetsky, E., Wasney, G. A., Chau, I., Marcellus, R. C., Hajian, T., Liu, F., et al. (2012) · Structure · doi:10.1016/j.str.2012.06.001 · Cited by 102
Self-citationAnglin, J. L., Deng, L., Yao, Y., Cai, G.-B., Liu, Z., Jiang, H., Cheng, G., Chen, P., Dong, S., & Song, Y. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300917h · Cited by 94
Structural Chemistry of the Histone Methyltransferases Cofactor Binding Site
Campágna‐Slater, V., Mok, M. W., Nguyen, K. T., Fehér, M., Najmanovich, R., & Schapira, M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100479z · Cited by 82
Exploiting an Allosteric Binding Site of PRMT3 Yields Potent and Selective Inhibitors
Liu, F., Li, F., Ma, A., Dobrovetsky, E., Dong, A., Gao, C., Korboukh, I., Liu, J., Smil, D. V., Brown, P. J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3018332 · Cited by 80
Self-citationGoyama, S., Nitta, E., Yoshino, T., Kako, S., Watanabe‐Okochi, N., Shimabe, M., Imai, Y., Takahashi, K., & Kurokawa, M. (2009) · Leukemia · doi:10.1038/leu.2009.202 · Cited by 80
Williams, D. E., Dalisay, D. S., Li, F., Amphlett, J. T. M., Maneerat, W., Chavez, M. A. G., Wang, Y. A., Matainaho, T. K., Yu, W., Brown, P. J., et al. (2012) · Organic Letters · doi:10.1021/ol303416k · Cited by 72
Self-citationLink, P. A., Gangisetty, O., James, S. R., Woloszynska‐Read, A., Tachibana, M., Shinkai, Y., & Karpf, A. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0497 · Cited by 59
Wigle, T. J., Provencher, L. M., Norris, J. L., Jin, J. J., Brown, P. J., Frye, S. V., & Janzen, W. P. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.014 · Cited by 49
Self-citationHauser, A., & Jung, M. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.615 · Cited by 5
Cited by
Epigenetics in cancer stem cells
Toh, T. B., Lim, J. J., & Chow, E. K.-H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0596-9 · Cited by 422
Marked for death: Targeting epigenetic changes in cancer
Pfister, S. X., & Ashworth, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.256 · Cited by 288
Chemical and Biochemical Perspectives of Protein Lysine Methylation
Luo, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00008 · Cited by 284
Ferry, L., Fournier, A., Tsusaka, T., Adelmant, G., Shimazu, T., Matano, S., Kirsh, O., Amouroux, R., Dohmae, N., Suzuki, T., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.012 · Cited by 203
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
Sweis, R. F., Pliushchev, M., Brown, P. J., Guo, J., Li, F., Maag, D., Petros, A. M., Soni, N. B., Tse, C., Vedadi, M., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400496h · Cited by 193
Self-citation
Metadata
- Authors
- Liu, F., Barsyte-Lovejoy, D., Li, F., Xiong, Y., Korboukh, V., Huang, X.-P., Allali-Hassani, A., Janzen, W. P., Roth, B. L., Frye, S. V., Arrowsmith, C. H., Brown, P. J., Vedadi, M., & Jin, J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-10-31
- Volume
- 56
- Issue
- 21
- Pages
- 8931-8942
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2065125513
- Cited by
- 268
- References
- 60
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
